{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:37:01Z","timestamp":1781613421564,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Case Reports in Women's Health"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.crwh.2020.e00277","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T12:12:54Z","timestamp":1607343174000},"page":"e00277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature"],"prefix":"10.1016","volume":"29","author":[{"given":"Giuseppe","family":"Caruso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Scopelliti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Scaramuzzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Galoppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocenza","family":"Palaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovico","family":"Muzii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi Benedetti","family":"Panici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crwh.2020.e00277_bb0005","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","article-title":"Incidence, mortality, and racial differences in peripartum cardiomyopathy","volume":"100","author":"Brar","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.crwh.2020.e00277_bb0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","article-title":"Pathophysiology and epidemiology of peripartum cardiomyopathy","volume":"11","author":"Hilfiker-Kleiner","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.crwh.2020.e00277_bb0015","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/ejhf.780","article-title":"Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM","volume":"19","author":"Sliwa","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.crwh.2020.e00277_bb0020","doi-asserted-by":"crossref","first-page":"k5287","DOI":"10.1136\/bmj.k5287","article-title":"Peripartum cardiomyopathy","volume":"364","author":"Honigberg","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.crwh.2020.e00277_bb0025","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","article-title":"Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review","volume":"283","author":"Pearson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.crwh.2020.e00277_bb0030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jacc.2011.03.047","article-title":"Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management","volume":"58","author":"Elkayam","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.crwh.2020.e00277_bb0035","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.crwh.2020.e00277_bb0040","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","article-title":"Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study","volume":"121","author":"Sliwa","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.crwh.2020.e00277_bb0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00395-013-0366-9","article-title":"Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy","volume":"108","author":"Haghikia","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.crwh.2020.e00277_bb0050","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/eurheartj\/ehx355","article-title":"Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study","volume":"38","author":"Hilfiker-Kleiner","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.crwh.2020.e00277_bb0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/eurjhf\/hfn034","article-title":"Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy","volume":"11","author":"de Jong","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.crwh.2020.e00277_bb0060","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1055\/s-0036-1584567","article-title":"Peripartum cardiomyopathy treatment with dopamine agonist and subsequent pregnancy with a satisfactory outcome","volume":"38","author":"Melo","year":"2016","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.crwh.2020.e00277_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/ejhf.1493","article-title":"Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy","volume":"21","author":"Bauersachs","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.crwh.2020.e00277_bb0070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","article-title":"Clinical outcomes for Peripartum cardiomyopathy in North America: results of the IPAC study (investigations of pregnancy-associated cardiomyopathy)","volume":"66","author":"McNamara","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.crwh.2020.e00277_bb0075","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1055\/s-0038-1675832","article-title":"Bromocriptine use in peripartum cardiomyopathy: review of cases","volume":"8","author":"Simon","year":"2018","journal-title":"AJP Rep."},{"key":"10.1016\/j.crwh.2020.e00277_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-118-3-199302010-00008","article-title":"Possible bromocriptine-induced myocardial infarction","volume":"118","author":"Larrazet","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.crwh.2020.e00277_bb0085","first-page":"415","article-title":"Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression","volume":"12","author":"Hopp","year":"1996","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.crwh.2020.e00277_bb0090","first-page":"1171","article-title":"Postpartum myocardial infarction induced by Parlodel","volume":"91","author":"Pop","year":"1998","journal-title":"Arch. Mal. Coeur Vaiss."},{"key":"10.1016\/j.crwh.2020.e00277_bb0095","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003088-200342070-00003","article-title":"Clinical pharmacokinetics of cabergoline","volume":"42","author":"Del Dotto","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.crwh.2020.e00277_bb0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tins.2007.06.004","article-title":"Is dopamine a physiologically relevant mediator of feeding behavior?","volume":"30","author":"Palmiter","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.crwh.2020.e00277_bb0105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bcpt.12307","article-title":"Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels","volume":"116","author":"Krysiak","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.crwh.2020.e00277_bb0110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000095530","article-title":"Acromegaly and the cardiovascular system","volume":"83","author":"Lombardi","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.crwh.2020.e00277_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11102-010-0290-z","article-title":"Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis","volume":"14","author":"dos Santos","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.crwh.2020.e00277_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2046-4053-1-33","article-title":"Treatment of hyperprolactinemia: a systematic review and meta-analysis","volume":"1","author":"Wang","year":"2012","journal-title":"Syst. Rev."}],"container-title":["Case Reports in Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214911220301077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214911220301077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T05:27:07Z","timestamp":1762406827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214911220301077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":24,"alternative-id":["S2214911220301077"],"URL":"https:\/\/doi.org\/10.1016\/j.crwh.2020.e00277","relation":{},"ISSN":["2214-9112"],"issn-type":[{"value":"2214-9112","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cabergoline as an adjuvant to standard heart failure treatment in peripartum cardiomyopathy: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Case Reports in Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crwh.2020.e00277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00277"}}